Patents by Inventor Angel L. Flye

Angel L. Flye has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Quantitative ZAP-70 assay
    Patent number: 8163510
    Abstract: An quantitative ZAP-70 assay is provided, with ZAP-70+ and ZAP-70? controls, normal human blood controls, an improved antibody with better signal to noise ratio, and using the median MEFL that is calibrated using a standard curve.
    Type: Grant
    Filed: July 19, 2010
    Date of Patent: April 24, 2012
    Assignee: Esoterix, Inc.
    Inventors: Keith E. Shults, Angel L. Flye, Leigh Ann Hobbs, David Miller
  • Quantitative Zap-70 Assay
    Publication number: 20110020844
    Abstract: An quantitative ZAP-70 assay is provided, with ZAP-70+ and ZAP-70? controls, normal human blood controls, an improved antibody with better signal to noise ratio, and using the median MEFL that is calibrated using a standard curve.
    Type: Application
    Filed: July 19, 2010
    Publication date: January 27, 2011
    Inventors: Keith E. Shults, Angel L. Flye, Leight Ann Hobbs, David Miller
  • Quantitative ZAP-70 assay
    Patent number: 7759076
    Abstract: An quantitative ZAP-70 assay is provided, with ZAP-70+ and ZAP-70? controls, normal human blood controls, an improved antibody with better signal to noise ratio, and using the median MEFL that is calibrated using a standard curve.
    Type: Grant
    Filed: October 14, 2005
    Date of Patent: July 20, 2010
    Assignee: Esoterix, Inc.
    Inventors: Keith E. Shults, Angel L. Flye, Leigh Ann Hobbs, David Miller
  • Cell fixation and use in phospho-proteome screening
    Patent number: 7326577
    Abstract: A new method of cell fixation using a mild denaturing heat and the fixative PERMIFLOW™ or similar fixative that preserves cell morphology, light scatter profiles, nucleic acid content, cell surface epitopes and unmasks internal epitopes previously not available. The method can be combined with analysis of each of these parameters by flow cytometry and thus has application in drug screening and patient or tumor monitoring protocols.
    Type: Grant
    Filed: August 13, 2004
    Date of Patent: February 5, 2008
    Assignee: Esoterix, Inc.
    Inventors: Keith E. Shults, Angel L. Flye